Abstract:Objectives: Progesterone (P4) expression failure and increased B-cell lymphoma 6 (BCL6) levels have been demonstrated in the endometrium of women with endometriosis and unexplained infertility In the present work, we studied BCL6 (P4 inhibitor) expression in relation to different hormonal exposures of the endometrium during the implantation window, as a predictor of poor reproductive results in “in vitro fertilization” procedures. BCL6 was investigated in endometrial biopsies from four infertile patients from the Reproductive Medicine Unit, Clinicas University Hospital “Jose de San Martín”, Buenos Aires, Argentina, using immunohistochemical techniques Materials and Methods: BCL6 was investigated in endometrial biopsies from four infertile patients from the Reproductive Medicine Unit, Clinicas University Hospital “Jose de San Martín”, Buenos Aires, Argentina, using immunohistochemical techniques Results: Four patients without suspicion of endometriosis but recurrent implantation failure were included in the analysis. They were all evaluated during the window of implantation. Two of them were under an artificial supplemented cycle with estradiol and progesterone for a frozen thawed embryo transfer, one was under high concentrations of endogenous oestrogen and progesterone due to a controlled ovarian stimulation regimen for an assisted reproductive technique, and one had a natural menstrual cycle. All patients exceeded the threshold level of the HSCORE for BCL6 (1.4). Conclusions: Abnormal endometrial expression of BCL6 participates in the development of P4 resistance in the endometrium. The BCL6 assay, performed prior to embryo transfer, could benefit women with suspected endometrial receptivity defects.

Increased Expression of BCL6 in Women with Implantation Failure